It is still the standard of care for people newly diagnosed with type 2 diabetes
The HRS9531-201 clinical trial was a multi-centre, randomised, double-blind, placebo-parallel controlled Phase 2 clinical study (NCT05881837) conducted by Hengrui Pharma in China to evaluate the efficacy and safety of HRS9531 injection in adults (aged 18-65) with obesity (BMI of 2840 kg/m2) without type 2 diabetes
Reutens AT, Jandeleit-Dahm K, Thomas M et al (2020) A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: protocol and statistical considerations
For many of us, its genetic and scientific
Hers offers various weight loss options, including oral medications, injections like Ozempic and Wegovy, and compounded GLP-1s
It may mean the body has adapted to a lower weight, calorie needs have changed, muscle preservation needs more attention, constipation or fluid shifts are masking progress, or the plan needs to be adjusted for the next phase of treatment
